Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Monte Rosa Therapeutics
221
Monte Rosa Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Suggest edits
Founded
2018
Raised
$32.5M
Follow us
Companies in the same industry
PDC*line Pharma
Confo Therapeutics
Longevity Biotech
Twentyeight-Seven Therapeutics
Carbiotix
Dyno Therapeutics
Artax Biopharma
Engrail Therapeutics
MiNA Therapeutics
Federation Bio
Overview
Funding
1
Add info
Latest funding
$32,500,000
Venture capital (Series A) - 2020
Versant Ventures
New Enterprise Associates
Team Size
1–10
Employees
I work here
Location
Switzerland
Headquarters
Explore Switzerland
$32,500,000
Venture capital (Series A)
FinSMEs
Monte Rosa Therapeutics Raises $32.5M Financing
